Arbutus Biopharma Corporation DPO Ratio 2011-2026 | ABUS

Annual DPO Ratio Arbutus Biopharma Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	23	15.2	20.1	11.6	19.2	18.5	19.3	20.7	16.2	-

All numbers in USD currency

Maximum	Minimum	Average
23	11.6	18.2

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	31.7	$ 21.43	5.2 %	$ 1 B	USA
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Akebia Therapeutics AKBA	168	$ 1.47	4.64 %	$ 378 M	USA
Aquestive Therapeutics AQST	395	$ 4.2	2.94 %	$ 449 M	USA
Arcutis Biotherapeutics ARQT	133	$ 24.1	-0.45 %	$ 3.07 B	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	4.06 K	$ 32.61	1.15 %	$ 2.17 B	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.47	-1.34 %	$ 391 M	Britain
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
Esperion Therapeutics ESPR	7.93 K	$ 2.23	2.53 %	$ 464 M	USA
Evogene Ltd. EVGN	62.6	$ 0.79	-2.54 %	$ 27.9 M	Israel
Baudax Bio BXRX	140	-	0.59 %	$ 63 K	USA